The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Body composition modulations during cyclic fasting-mimicking diet in patients with advanced solid cancers.
 
Caterina Sposetti
No Relationships to Disclose
 
Francesca Ligorio
No Relationships to Disclose
 
Roberta Serino
No Relationships to Disclose
 
Andrea Franza
No Relationships to Disclose
 
Giuseppe Fotia
No Relationships to Disclose
 
Moreno Marino
No Relationships to Disclose
 
Francesca Greco
No Relationships to Disclose
 
Raffaella Vigorito
No Relationships to Disclose
 
Alfonso Marchianò
No Relationships to Disclose
 
Giancarlo Pruneri
Honoraria - AstraZeneca; Genomic Health; Menarini; Novartis; Roche
Consulting or Advisory Role - ADS Biotec; ADS Biotec; ADS Biotec
Research Funding - Roche; Roche Molecular Diagnostics
 
Jennifer Ligibel
No Relationships to Disclose
 
Filippo De Braud
Honoraria - BMS; Incyte; Indena; IQVIA; Mattioli 1885; MCCann Health; Menarini; MSD; Pierre Fabre; Taiho Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Pierre Fabre; Sanofi; Taiho Oncology
Speakers' Bureau - Ambrosetti; BMS; Dephaforum; Nadirex International; Novartis
Research Funding - AnHeart Therapeutics; Apollomics; AstraZeneca; BMS
Travel, Accommodations, Expenses - Sanofi
 
Claudio Vernieri
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Menarini Group; Novartis; Pfizer
Speakers' Bureau - Accademia Nazionale Di Medicina (ACCMED); AstraZeneca; Istituto Gentili; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Roche